Discussion: Comment on a paper by Jager and Leek.

REFERENCES ABRAMOVICH, F., BENJAMINI, Y., DONOHO, D. AND JOHNSTONE, I. M. (2006). Adapting to unknown sparsity by controlling the false discovery rate. The Annals of Statistics 34, 584–653. BENJAMINI, Y. (2010). Simultaneous and selective inference: current successes and future challenges. Biometrical Journal 52(6), 708–721, doi:10.1002/bimj.200900299. BENJAMINI, Y. AND YEKUTIELI, Y. (2005). False discovery rate controlling confidence intervals for selected parameters. Journal of the American Statistical Association 100, 71–80. COHEN, R. (2013). Hierarchical weighted methods that control the false discovery rate and their use in medical research. Tel Aviv University, [PhD. Thesis]. FLETCHER, S. W. AND COLDITZ, G. A. (2002). Failure of estrogen plus progestin therapy for prevention. Journal of the American Medical Association, 288, 366–369. KAPLAN (2008). Current Dilemma in Drug Development Increasing Failure Rate of investigational Drugs in Phase 3. http://powershow.com/view1/183eb3-YjZmY/Current Dilemma in Drug Development Increasing Failure Rate of Investigational Drugs in Phase 3 Clin powerpoint ppt presentatio. SORIÇ, B. (1989). Statistical “discoveries” and effect size estimation. Journal of the American Statistical Association 84, 608–610.